Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent meningococcal conjugate vaccine booster in children primed as toddlers
2017-001993-40Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Meningococcal ACWY conjugate vaccine in meningococcal disease, sponsored by Sanofi. Primary endpoints: Immunogenicity and Safety. Started Oct 2017; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-001993-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001993-40.